Search results
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.
- Team
Tim Kutzkey, PhD. Position: Managing Partner. Tim Kutzkey,...
- Portfolio
Denotes acquired investment. Denotes public company. KENAI...
- Careers
Senior Manager, Site Engagement and Monitoring Excellence...
- Contact
The Column Group. 1 Letterman Drive. Building D, Suite...
- TCG News
The Column Group launches a novel ‘venture-biotech’ model,...
- Portfolio News
NGM Bio Announces $122 Million Series A Financing to...
- Tim Kutzkey, PhD
Tim Kutzkey, Ph.D., is a Managing Partner of The Column...
- Team
Denotes acquired investment. Denotes public company. KENAI THERAPEUTICS. Kenai is pioneering the development and manufacture of novel off-the-shelf induced pluripotent stem cell (iPSC) based therapies for the treatment of neurodegenerative disorders, including Parkinson’s disease.
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique...
Dec 18, 2023 · Founded in 2007, The Column Group is a venture capital firm based in San Francisco, California. The firm prefers to invest in seed-stage and early-stage companies operating in healthcare, life sciences, oncology, drug discovery, and technology-based sectors in the United States.
Apr 20, 2021 · Science-driven VC firm The Column Group set up its debut crossover fund with an oversubscribed $824 million to start. Dubbed TCG Crossover, TCG X for short, will invest in both public and private drug development companies.
People also ask
Who is the column group?
Who is Evangelista from the column group?
Who is Dr Ray from the column group?
Jun 13, 2012 · The Column Group is a venture capital firm dedicated to developing biotechnology companies. View contacts for The Column Group to access new leads and connect with decision-makers.